Author:
Gulay Kevin Christian M.,Aoshima Keisuke,Maekawa Naoya,Suzuki Tamami,Konnai Satoru,Kobayashi Atsushi,Kimura Takashi
Abstract
AbstractHemangiosarcoma (HSA) is a malignant tumor derived from endothelial cells. Tumor-associated macrophages are one of the major components of tumor microenvironment and crucial for cancer development. The presence and function of macrophages in HSA have not been studied because there is no syngeneic model for HSA. In this study, we evaluated two mouse HSA cell lines and one immortalized mouse endothelial cell line for their usefulness as syngeneic models for canine HSA. Our results showed that the ISOS-1 cell line developed tumors with similar morphology to canine HSA. ISOS-1 cells highly expressed KDM2B and had similar KDM2B target expression patterns with canine HSA. Moreover, we determined that in both ISOS-1 and canine HSA tumors, macrophages were present as a major constituent of the tumor microenvironment. These macrophages were positive for CD204, an M2 macrophage marker, and express PD-L1, an immune checkpoint molecule. Canine HSA with macrophages expressing PD-L1 had a smaller number of T-cells in tumor tissues than tumors with PD-L1 negative macrophages. ISOS-1-conditioned medium could induce M2 polarization and PD-L1 expression in RAW264.7 mouse macrophage cell line and mouse peritoneal macrophages. These results show that ISOS-1 can be used as a syngenic model for canine HSA and suggest that macrophages play an important role in immune evasion in HSA. Using the syngeneic mouse model for canine HSA, we can further study the role of immune cells in the pathology of HSA.
Funder
Japan Society for the Promotion of Science
The Kuribayashi foundation
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Spangler, W. L. & Culbertson, M. R. Prevalence, type, and importance of splenic diseases in dogs: 1,480 cases (1985–1989). J. Am. Vet. Med. Assoc. 200, 829–834 (1992).
2. Prymak, C., McKee, L. J., Goldschmidt, M. H. & Glickman, L. T. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J. Am. Vet. Med. Assoc. 193, 706–712 (1988).
3. Johannes, C. M. et al. Hemangiosarcoma in cats: 53 cases (1992–2002). J. Am. Vet. Med. Assoc. 231, 1851–1856 (2007).
4. Southwood, L. L. et al. Disseminated hemangiosarcoma in the horse: 35 cases. J. Vet. Intern. Med. 14, 105–109 (2000).
5. Cohen, S. M. et al. Hemangiosarcoma in rodents: Mode-of-action evaluation and human relevance. Toxicol. Sci. 111, 4–18 (2009).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献